CNO Financial (CNO) Cash & Equivalents (2009 - 2025)

CNO Financial (CNO) has 17 years of Cash & Equivalents data on file, last reported at $956.1 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $956.1 million, up 168.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $956.1 million (up 168.72% YoY), and the FY2025 annual result was $956.1 million, up 168.72% from the prior year.
• Cash & Equivalents grew to $956.1 million in Q4 2025 per CNO's latest filing, from $355.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $1.2 billion in Q3 2024 and troughed at $196.2 million in Q4 2021.
• A 5-year average of $612.0 million and a median of $566.3 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2021 and 2022: Cash & Equivalents tumbled 79.08% in 2021, then surged 193.43% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $196.2 million in 2021, then surged by 193.43% to $575.7 million in 2022, then surged by 34.53% to $774.5 million in 2023, then tumbled by 54.06% to $355.8 million in 2024, then surged by 168.72% to $956.1 million in 2025.
• Business Quant data shows CNO's Cash & Equivalents at $956.1 million in Q4 2025, $355.8 million in Q4 2024, and $1.2 billion in Q3 2024.